FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer
The U.S. Food and Drug Administration (FDA) granted accelerated approval to tazemetostat for the treatment…
The U.S. Food and Drug Administration (FDA) granted accelerated approval to tazemetostat for the treatment…